Power To The (Adcomm) People: Members Believe Votes Should More Directly Affect US FDA Decisions
Executive Summary
A survey of advisory committee members finds many believe that an overwhelmingly negative vote should prevent a product approval.
You may also be interested in...
Will Amylyx’s ALS Drug Benefit From US FDA’s Aduhelm Experience?
A rare second advisory committee meeting is scheduled for Amylyx’s ALS drug to discuss additional analyses that the company submitted, allowing another glimpse into the FDA’s pre-decision thinking.
US FDA’s Califf Expects Advisory Committee Reform Talk ‘About A Year From Now’
The FDA commissioner said several aspects of the advisory committee system should be considered for updates or adjustment. A revamp effort has predated his return trip to the agency.
Califf And Advisory Committees: Will He Push For Reforms?
Confirmation hearing comment suggests FDA Commissioner nominee Robert Califf thinks an overwhelming advisory committee vote should give agency officials pause.